GlassScriptPhysician profile
Navid Berenji
NPI 1477086031
$3,054.61
in general payments reported to CMS, 2019-2025
22 companies · $603 in 2025
The $603 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $661 · 2022: $763 · 2023: $341 · 2024: $688 · 2025: $603.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,558 · Education: $73.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,557.60 |
| Education | $73.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $545.83 | 2021-2023 | Onyx Frontier |
| Abbott Laboratories | $476.68 | 2021-2025 | Cardiomems, Xience Skypoint, Diamondback Coronary |
| Abiomed | $432.98 | 2023-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $262.04 | 2022-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $209.94 | 2021-2025 | Farxiga |
| Amgen INC. | $180.85 | 2022-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $161.31 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Irhythm Technologies, INC. | $158.21 | 2024 | Zio Monitor, Zio Xt Patch, Zio At Patch |
| Novartis Pharmaceuticals Corporation | $128.79 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $84.23 | 2021-2022 | |
| Chiesi USA, INC. | $72.00 | 2023 | Kengreal |
| Edwards Lifesciences Corporation | $63.39 | 2022-2024 | Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $56.87 | 2022-2025 | Camzyos |
| Penumbra, INC. | $48.00 | 2023 | Indigo System |
| Pfizer INC. | $40.96 | 2023-2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $24.01 | 2024 | Metacross Otw |
| Philips North America LLC | $22.51 | 2022 | |
| Impulse Dynamics (USA) INC. | $21.26 | 2023 | Optimizer |
| Alnylam Pharmaceuticals INC. | $19.66 | 2021 | |
| Teleflex LLC | $15.93 | 2024 | Bandit |
| Merck Sharp & Dohme LLC | $14.79 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $14.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Navid Berenji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.